Cargando…

Combination therapy of RY10-4 with the γ-secretase inhibitor DAPT shows promise in treating HER2-amplified breast cancer

RY10-4, a novel protoapigenone analog, shows potent cytotoxicity against human breast cancer cells. However, breast cancer cell lines overexpressing human epidermal growth factor receptor 2 (HER2), SKBR3 and BT474, showed less sensitivity to RY10-4 when compared to breast cancer cells lines expressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Feng, Zhu, Shilin, Ruan, Jinlan, Muftuoglu, Yagmur, Zhang, Longbo, Yuan, Qianying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826195/ https://www.ncbi.nlm.nih.gov/pubmed/26716652 http://dx.doi.org/10.18632/oncotarget.6769

Ejemplares similares

Gastric cancer cell growth and epithelial-mesenchymal transition are inhibited by γ-secretase inhibitor DAPT
por: LI, LU-CHUN, et al.
Publicado: (2014)

γ‐secretase inhibitor DAPT mitigates cisplatin‐induced acute kidney injury by suppressing Notch1 signaling
por: Soni, Hitesh, et al.
Publicado: (2018)

DAPT, a γ-Secretase Inhibitor, Suppresses Tumorigenesis, and Progression of Growth Hormone-Producing Adenomas by Targeting Notch Signaling
por: Feng, Jie, et al.
Publicado: (2019)

Effect of DAPT, a gamma secretase inhibitor, on tumor angiogenesis in control mice
por: Kalantari, Elmira, et al.
Publicado: (2013)

Confocal Raman Spectral Imaging Study of DAPT, a γ-secretase Inhibitor, Induced Physiological and Biochemical Reponses in Osteosarcoma Cells
por: Li, Jie, et al.
Publicado: (2020)

γ‐Secretase modulators show selectivity for γ‐secretase–mediated amyloid precursor protein intramembrane processing
por: Weber, Tobias A., et al.
Publicado: (2021)

γ-secretase inhibitors, DAPT and RO4929097, promote the migration of Human Glioma Cells via Smad5-downregulated E-cadherin Expression
por: Chang, Shun-Fu, et al.
Publicado: (2021)

A promising new γ-secretase modulator for Alzheimer’s disease
por: Dobrowolska Zakaria, Justyna A., et al.
Publicado: (2021)

Substrate docking to γ-secretase allows access of γ-secretase modulators to an allosteric site
por: Uemura, Kengo, et al.
Publicado: (2010)

Presenilin/γ-Secretase and Inflammation
por: Saura, Carlos A.
Publicado: (2010)

γ-Secretase in Alzheimer’s disease
por: Hur, Ji-Yeun
Publicado: (2022)

N-{N-[2-(3,5-Difluorophenyl)acetyl]-(S)-alanyl}-(S)-phenylglycine tert-butyl ester (DAPT): an inhibitor of γ-secretase, revealing fine electronic and hydrogen-bonding features
por: Czerwinski, Andrzej, et al.
Publicado: (2010)

RY10-4 Inhibits the Proliferation of Human Hepatocellular Cancer HepG2 Cells by Inducing Apoptosis In Vitro and In Vivo
por: Zhang, Xuenong, et al.
Publicado: (2016)

γ-Secretase modulators exhibit selectivity for modulation of APP cleavage but inverse γ-secretase modulators do not
por: Lessard, Christian B., et al.
Publicado: (2020)

The Cornelian dilemma(†) of quitting DAPT
por: Motovska, Zuzana, et al.
Publicado: (2021)

Correlations of DAPT score and PRECISE-DAPT score with the extent of coronary stenosis in acute coronary syndrome
por: Long, Tianyi, et al.
Publicado: (2018)

Contradictions between DAPT and PRECISE-DAPT scores with the severity of coronary lesion in acute coronary syndrome
por: Bi, Sisi, et al.
Publicado: (2020)

Structure-function relationship of γ-secretase
por: Tomita, Taisuke
Publicado: (2012)

The dynamic conformational landscape of γ-secretase
por: Elad, Nadav, et al.
Publicado: (2015)

Presenilins and γ-Secretase in Membrane Proteostasis
por: Oikawa, Naoto, et al.
Publicado: (2019)

The cytotoxicity of γ-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by γ-secretase inhibition
por: Han, Jianxun, et al.
Publicado: (2009)

Complex Relationships between Substrate Sequence and Sensitivity to Alterations in γ-Secretase Processivity Induced by γ-Secretase Modulators
por: Jung, Joo In, et al.
Publicado: (2014)

The effects of dual antiplatelet therapy (DAPT) adherence on survival in patients undergoing revascularization and the determinants of DAPT adherence
por: Zhang, Shuqi, et al.
Publicado: (2022)

Development of a High-Throughput Assay for Screening of γ-Secretase Inhibitor with Endogenous Human, Mouse or Drosophila γ-Secretase
por: Wang, Lie-Feng, et al.
Publicado: (2009)

Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration
por: Toyota, Toshiaki, et al.
Publicado: (2017)

Biogenesis of γ-secretase early in the secretory pathway
por: Kim, Jinoh, et al.
Publicado: (2007)

Effects of γ-secretase inhibitors in mouse colon
Publicado: (2012)

Mechanism of Intramembrane Cleavage of Alcadeins by γ-Secretase
por: Piao, Yi, et al.
Publicado: (2013)

Structural basis of human γ-secretase assembly
por: Sun, Linfeng, et al.
Publicado: (2015)

γ-Secretase: a multifaceted regulator of angiogenesis
por: Boulton, Michael E, et al.
Publicado: (2008)

The γ-secretase complex: from structure to function
por: Zhang, Xian, et al.
Publicado: (2014)

γ‐Secretase Dependent Nuclear Targeting of Dystroglycan
por: Leocadio, Daniel, et al.
Publicado: (2016)

Mechanisms of γ-Secretase Activation and Substrate Processing
por: Bhattarai, Apurba, et al.
Publicado: (2020)

Enzyme–substrate interface targeting by imidazole‐based γ‐secretase modulators activates γ‐secretase and stabilizes its interaction with APP
por: Petit, Dieter, et al.
Publicado: (2022)

PEDF Regulates Vascular Permeability by a γ-Secretase-Mediated Pathway
por: Cai, Jun, et al.
Publicado: (2011)

Interplay between α-, β-, and γ-Secretases Determines Biphasic Amyloid-β Protein Level in the Presence of a γ-Secretase Inhibitor
por: Ortega, Fernando, et al.
Publicado: (2013)

γ-Secretase Modulators and APH1 Isoforms Modulate γ-Secretase Cleavage but Not Position of ε-Cleavage of the Amyloid Precursor Protein (APP)
por: Lessard, Christian B., et al.
Publicado: (2015)

The mechanism of γ-Secretase dysfunction in familial Alzheimer disease
por: Chávez-Gutiérrez, Lucía, et al.
Publicado: (2012)

Presenilin/γ-Secretase Regulates Neurexin Processing at Synapses
por: Saura, Carlos A., et al.
Publicado: (2011)

Presenilins and the γ-secretase: still a complex problem
por: Small, David H, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_iaoc68llobc1oh33er1g9grmmv